منبع: Reuters
خبرگزاری
عمومی
اهمیت متوسط
Sionna scraps genetic disorder drug program after trial setback; shares tank
Sionna Therapeutics said on Monday it would stop developing its experimental drug as an addition to standard treatment for a type of genetic disorder after it failed to show a meaningful benefit in a mid-stage trial.
منبع: Reuters
مشاهده منبع